BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 12315276)

  • 1. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K; Howard G
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-a-month estrogen/progestogen injectables.
    D'arcangues C
    Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.
    Pardthaisong T; Gray RH; McDaniel EB
    Lancet; 1980 Mar; 1(8167):509-12. PubMed ID: 6102234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S; Hernandez C; Nava MP; Trujillo AM; Luz de la Cruz D
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of ovulation return upon discontinuation of once-a-month injectable contraceptives.
    Bassol S; Garza-Flores J
    Contraception; 1994 May; 49(5):441-53. PubMed ID: 8045131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Return of fertility after use of the injectable contraceptive Depo Provera: up-dated data analysis.
    Pardthaisong T
    J Biosoc Sci; 1984 Jan; 16(1):23-34. PubMed ID: 6230362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Return of ovulation and fertility in women using norethisterone oenanthate.
    Fotherby K; Yong-En S; Howard G; Elder MG; Muggeridge J
    Contraception; 1984 May; 29(5):447-55. PubMed ID: 6744861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception for the older woman.
    Guillebaud J
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S70-7. PubMed ID: 12268772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of "once-a-month" combined injectable contraceptives.
    Newton JR; D'arcangues C; Hall PE
    J Obstet Gynaecol (Lahore); 1994; 4 Suppl 1():S1-34. PubMed ID: 12290848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemics.
    Netw Res Triangle Park N C; 1985; 6(3):1-3. PubMed ID: 12280131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statement on injectable contraception. Revised.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1992 Dec; 26(6):4-6. PubMed ID: 12346921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
    Garza-Flores J; Cardenas S; Rodríguez V; Cravioto MC; Diaz-Sanchez V; Perez-Palacios G
    Contraception; 1985 Apr; 31(4):361-6. PubMed ID: 3159544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
    Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
    Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.